Skip to main content

Table 2 Participant characteristics

From: Prehabilitation in high-risk patients scheduled for major abdominal cancer surgery: a feasibility study

 

Overall (n=50)

Gender (male, n (%))

26 (52%)

Age (years), median [IQR]

71 [63–77]

Age (years), range

44–84

Colinet Comorbidity Score, median [IQR]

10.5 [6.75–12.25]

ARISCAT, n (%)

 Intermediate risk

27 (54%)

 High risk

23 (46%)

At risk of malnutrition, n (%)a

 Yes

16 (40%)

 No

27 (63%)

Cancer type, n (%)

 Colorectal

32 (64%)

 Oesophageal

9 (18%)

 Sarcoma

6 (12%)

 Pancreatic

1 (2%)

 Prostate

1 (2%)

 Gastric

1 (2%)

Surgery type, n (%)

 Bowel resection

12 (24%)

 Oesophagectomy

9 (18%)

 Cytoreductive surgery with HIPEC

8 (16%)

 Pelvic exenteration

6 (12%)

 Ultra-low anterior resection

6 (12%)

 Sarcoma resection

3 (6%)

 Pancreatectomy

1 (2%)

 Prostatectomy

1 (2%)

 Gastrectomy

1 (2%)

 Debulking surgery

1 (2%)

 Reversal of Hartmans

1 (2%)

 Whipples operation

1 (2%)

CPET-derived variables

 AT (mL/kg/min), mean±SD

9.8±1.8

 VO2 Peak (mL/kg/min), mean±SD

14.0±2.9

 VO2 Peak/BSA (mLs/kg), mean±SD

578±121

Smoking status, n (%)

 Never smoked

13 (26%)

 Quit smoking >2 months

32 (64%)

 Current smoker

5 (10%)

Living situation, n (%)

 Living alone

9 (18%)

 Living with family

41 (82%)

Residing >30km from hospital, n (%)

34 (68%)

Reported currently not exercising, n (%)

40 (80%)

  1. Abbreviations: ARISCAT Assess Respiratory Risk in Surgical Patients in Catalonia, BSA body surface area, CPET cardiopulmonary exercise test, HIPEC hyperthermic intraperitoneal chemotherapy. an=43, 7 missing Malnutrition Screening Tool Results